Exclusive coverage of the 2016 inaugural 'Inspiring Hope' Ideathon Copy
Views & Analysis
News
Novartis raises mid-term sales outlook on pipeline promise
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Market Access
Looking to history to prepare for America’s uncertain future
In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Returning... The 5th Operationalize Expanded Access Programs...
Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
R&D
Partner Content
LEAP HR: Life Sciences Europe
Save the Date for LEAP HR: Life Sciences Europe! 18th-20th February, 2025, London, UK.
Category :
Views & Analysis
/
Clinical
